This statement provides new recommendations for targeted tuberculin testing and treatment regimens for persons with latent tuberculosis infection (LTBI) and updates previously published guidelines. This statement is issued in recognition of the importance of these activities as an essential component of the TB Elimination Strategy promoted by the U.S. Public Health Service Advisory Council on the Elimination of Tuberculosis, and reports the deliberations of expert consultants convened by the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC). - p. This report is being published with the permission of the American Thoracic Society and as a courtesy to the MMWR readership. It is an adaptation of a report published in the American Journal of Respiratory and Critical Care Medicine 2000;161:S221--S247. - p. v Includes bibliographical references (p. 43-51).

Writen by the ATS/CDC Statement Committee on Latent Tuberculosis Infection, co-chairs: David L. Cohn, Richard J. O'Brien. The material in this report was prepared for publication by National Center for HIV, STD, and TB Prevention Division of Tuberculosis Elimination.

10881762

Guidelines and Recommendations